19th October

08:30-10:00

Registration

10:00-10:30

Opening ceremony - Welcome addresses

M. Melato, Anatomia Patologica, Ospedali Gorizia e Monfalcone, Italy
G. Mustacchi, Medical Oncology, Cancer Center, Trieste, Italy

10:30-11:00

Introduction to the conference

G.D. Birkmayer, Medical Chemistry Department, University of Graz, Austria
P.M. Biava,IRCCS Multimedica, Milan, Italy

11:00-11:30

Keynote lecture

Evolving strategies and new indications for hemopoietic stem cell transplantation,
G. Lambertenghi Deliliers, Centro Trapianti Midollo, Milan, Italy [presentation]

11:30-13:00

1st SESSION
PROGRESS IN BLOOD CANCER

Chairpersons:
P.M. Biava, IRCCS Multimedica, Milano, Italy
M. Bizzarri, University “La Sapienza”, Rome, Italy

Biological markers in the characterization of multiple myeloma,
A. Neri,IRCCS Ospedale Maggiore, Policlinico Milan, Italy [presentation]

Advances in clinical management of chronic lymphatic leucemia,
M.C. Pasquini, IRCCS Ospedale Maggiore, Policlinico Milan, Italy [presentation]

Novel therapeutic approaches in cutaneous T-cell lymphomas,
F. Onida,IRCCS Ospedale Maggiore, Policlinico Milan, Italy [presentation]

Thrombotic events in hematological malignancies,
A. Federici, IRCCS Ospedale Maggiore, Policlinico Milan, Italy [presentation]

13:00-14:30

Lunch

14:30-16:00

2nd SESSION
STEM CELL DIFFERENTIATION (SCD) AND CANCER

Chairpersons:
G. Lambertenghi Deliliers, Centro Trapianti Midollo, Milan, Italy
S. Sell, Wadsworth Research Center Albany, New York, USA

Therapeutic strategies for cancer stem cells,
S. Sell, Wadsworth Research Center Albany, New York, USA [presentation]

Cancer and SCD stage factors: the role of epigenetic code in tumor growth control,
P.M. Biava, IRCCS Multimedica, Milano, Italy [presentation]

Apoptosis and growth-inhibition induced by embryonic Zebrafish proteins in colon cancer cells. Synergy between SCD stage factors and Fluouracil,
M. Bizzarri, University “La Sapienza”, Rome, Italy

SCD stage factor as a possible new approach for liver transplantation waiting list management of HCC,
A. Frosi, Ospedale Sesto S. Giovanni, Milan, Italy [presentation]

Use of SCD stage factors in bisphosphonates osteonecrosis of the jaw,
F. Bigliocca, Studio Medico Dr. Ennas, Monza Milan, Italy [presentation]

16:00-16:15

Coffee break

16:15-17:15

3rd SESSION
METABOLOMICS AND CANCER

Chairpersons:
P.M. Biava, IRCCS Multimedica, Milan, Italy
L. Moro, Biochemical Department University of Trieste, Italy

The role of metabolomics in the study of cancer,
F. Conti, University “La Sapienza”, Rome, Italy [presentation]

Diagnostic integration of metabolomics and histopathology,
G. Lanzetta, INI, Oncological Department, Grottaferrata Rome, Italy [presentation]

Evaluation of the activities of antitumor drugs in cancer cell lines by 1H NMR-based metabolomics,
M. C. Valerio, University “La Sapienza”, Rome, Italy [presentation]

17:15-18:15

4th SESSION
TUMOR MARKERS IN DIFFERENT TUMORS

Chairpersons:
F. Conti, University “La Sapienza”, Rome, Italy
O. Topolcan, Immunoanalytical laboratory, University Hospital, Plzen, Czech Republic

Chromogranin A,
O. Topolcan, Immunoanalytic laboratories, Faculty of Medicine in Pilsen, Charles University in Prague, Czech Republic [presentation]

Cytokeratins in lung cancer
O. Topolcan, Immunoanalytic laboratories, Faculty of Medicine in Pilsen, Charles University in Prague, Czech Republic [presentation]

Study of hTERT and c-myc expression and telomerase activity in neoplastic thyroid tissues and autoimmune thyroiditis
A.I. Glukhov, Department of Biochemistry, Medical Faculty, I.M.Sechenov Moscow Medical Academy, Moscow, Russia

Study of survivin expression in melanomas and adrenal and thyroid neoplasms
S.A. Gordeev, Moscow Research Institute of Medical Ecology, Moscow, Russia

20th October

09:00-11:00

5th SESSION
GENITO-URINARY TRACT TUMORS

Chairpersons:
E. Imparato, Policlinico San Matteo, IRCCS, Pavia, Italy
S. Guaschino, Gynecologic Department, University of Trieste, Italy

Human papillomavirus vaccination,
M. Sideri, Istituto Oncologico Europeo, Milan, Italy

Cervical cancerogenesis in HIV sieropositive women. A biological model,
A. Spinillo, IRCCS Policlinico San Matteo, Pavia, Italy

The role of robotic surgery in gynecologic oncology,
A. Maggioni, M. Peiretti, Istituto Oncologico Europeo, Milan, Italy

Serum Vascular Endothelial Growth Factor (VEGF) level & its significance in ovarian cancer
E. Rizq, Clinical Pathology & Obstetric & Gynaecology Departments Faculty of Medicine Alexandria University, Alexandria Egypt [presentation]

11:00-11:15

Coffee break

11:15-13:00

6th SESSION
BREAST CANCER

Chairperson:
G. Mustacchi,Medical Oncology, Cancer Center, Trieste, Italy
N.J. Agnantis, Institute of Pathology, University of Ioannina, Greece

Alterations of the cell cycle regulating proteins, apoptosis and cell proliferation in breast cancer,
N.J. Agnantis, Institute of Pathology, University of Ioannina, Greece [presentation]

Updated management in inflammatory breast cancer,
I. Roisman, Breast Unit Horev Medical Center, Haifa, Israel [presentation]

Bone markers in bone metastases
H. Oguz Soydinc, Istanbul University, Oncology Institute, Capa Istanbul, Turkey [presentation]

14:30-16:00

7th SESSION
INTEGRATED THERAPIES OF CANCER

Chairpersons:
B. Rocca, Policlinico Mangiagalli e Regina Elena, Milan, Italy
F. Burigana, AMeC, Trieste, Italy

Complementary medicine in the cancer patients' care,
M. Levy, Clalit Complementary Medicine, Israel [presentation]

Homeopathic therapy to control chemotherapy-induced peripheral neuropathy: a randomized study,
A. Laffranchi, IRCCS Istituto Nazionale Tumori, Milan, Italy [presentation]

The Ramakrishnan method,
A.U. Ramakrishnan, Scientific Advisory Board, New Delhi, India [presentation]

Anthroposophical medicine and integrated therapy of cancer,
E. Portalupi, ARESMA, SIMA, Milan, Italy [presentation]

Correlations between tissular acidosis, biophysiologic parameters, m.u.s., chronic–degenerative pathologies and cancer
E. Sclauzero, M.M.G. ASS 5, “Bassa Friulana”, Bagnaria Arsa Udine, Italy [presentation]

16:00-16:30

Coffee break and POSTER SESSION

Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
M. Bizzarri, University “La Sapienza”, Rome, Italy

NMR-Spectrocopy-based metabolomics of human hepatocarcinoma cell line: on integrated approach to tumor metabolome
R. Di Clemente, Department of Chemistry, University “La Sapienza”, Rome, Italy

Survivin levels in cancer
H. O. Soydinc, Istanbul University, Oncology Institute, Capa Istanbul, Turkey

The expression of mRNA of MMP-2, MMP-7, MMP-9, TIMP-1 and TIMP-2 and CEA as prognostic factors in patients with colorectal liver metastases
O. Topolcan, Department of Oncology, University Hospital and Medical Faculty, Pilsen, Czech Republic

The diagnostic and prognostic significance cytokeratins and thymidine kinase as markers in oncology
O. Topolcan, Department of Oncology, University Hospital and Medical Faculty, Pilsen, Czech Republic

13C NMR-Spectrocopy-based metabolic profiling of cancer cell growth
M. C. Valerio, Department of Chemistry, University “La Sapienza”, Rome, Italy

16:30-18:00

8th SESSION
INTEGRATED THERAPIES OF CANCER

Chairperson:
M. Levy, Clalit Complementary Medicine, Israel
I. Roisman, Breast Unit Horev Medical Center, Haifa, Israel

Quantum Molecular Medicine (QMM),
B. Rocca, Policlinico Mangiagalli e Regina Elena, Milan, Italy [presentation]

Manual muscle test on a muscle under weak magnetic field in cancer patient,
F. Burigana, AMeC, Trieste, Italy
P. Giribona, Health Robotics, Trieste, Italy [presentation]

Laboratory studies of homeopathic medicines. An update,
P. Bellavite, University of Verona, Italy [presentation]

Use of homeopathy in the treatment of menopausal symptoms in patients operated for early breast cancer,
F. Desiderio, Oncological prevention service, AUS Rimini, Italy [presentation]

21st October

09:00-11:00

9th SESSION
INTEGRATED THERAPIES AND NEW TREATMENTS OF CANCER

Chairpersons:
G.D. Birkmayer, Medical Chemistry Department, University of Graz, Austria
M. Arlen, Neogenix Oncology Inc., New York, USA

The role of NADH in cancer therapy,
G.D. Birkmayer, Medical Chemistry Department, University of Graz, Austria [presentation]

The therapeutic value of protein monoclonal antibodies directed against immunogenic tumor glycoproteins,
M. Arlen, Neogenix Oncology Inc., New York, USA [presentation]

Metabolomics in the context of systems biology: bridging traditional herb based medicine and molecular pharmacology,
M. Bizzarri, University “La Sapienza”, Rome, Italy

Antioxidants in cancer prevention and therapy,
A.M. Pasciuto, AdEAV, Rome, Italy [presentation]

Hypoxia, oxidative stress and cancer. New possible integrated strategies,
E. L. Iorio, Osservatorio internazionale dello stress ossidativo [presentation]

Abstract presentation:
L. Afrasyap, School of Health Sciences, Mugla University, Mugla, Turkey

11:00-11:15

Coffee break

11:15-13:00

10th SESSION
SKIN CANCER

Chairpersons:
G.D. Birkmayer, Medical Chemistry Department, University of Graz, Austria
L. Marini, The Skin Doctors' Center, Trieste, Italy

Cutaneous malignant melanoma,
D. Calista, Ospedale M. Bufalini, Cesena, Italy [presentation]

Non melanoma skin cancer,
E. Haneke, Dermaticum, Freiburg, Germany & Dept. Dermatol., Inselspital, University of Bern, Switzerland [presentation]

Mohs’ micrographic surgery: an optimal treatment for selected non melanoma skin cancer,
L. Marini, The Skin Doctors' Center, Trieste, Italy [presentation]

New nevi and new melanoma, cases of medicolegal relevance,
G. Massi, Catholic University Medical School, Rome, Italy

13:00-13:15

Conference conclusions